Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 August 2024 | Story André Damons | Photo Supplied
Prof Patricks Voua Otomo
Prof Patricks Voua Otomo, Associate Professor and subject head of Department of Zoology and Entomology at the University of the Free State (UFS).

In an effort to alleviate the burden of water contamination, Prof Patricks Voua Otomo, Associate Professor in the Department of Zoology and Entomology at the University of the Free (UFS) is researching how mushrooms can be used to significantly reduce the toxicity of water.

The degradation of river systems in South Africa has been linked primarily to the inability of municipalities to properly treat wastewater. According to the 2022 Green Drop Report, out of the existing 850 wastewater systems across 90 municipalities, only 23 (or less than 3%) qualified for the Green Drop Certification. This underscores the depth and breadth of the wastewater treatment crisis in South Africa and its potential implications for human and environmental health.

In 2030, billions of people will still lack access to safe water, sanitation and hygiene services – the most basic human need for health and well-being. Target 6.1 of the United Nations (UN) Sustainable Development Goals (SDGs) – SDG 6 – aims to achieve universal and equitable access to safe and affordable drinking water for all, while target 6.3 is also looking to improve water quality by reducing pollution, eliminating dumping and minimising release of hazardous chemicals and materials, halving the proportion of untreated wastewater and substantially increasing recycling and safe re-use globally by 2030.

These challenges inform Prof Voua Otomo’s research, which focuses on the drivers of river pollution in the Qwaqwa region, ways to mitigate/remediate their effects, and the development of simple and quick methods to assess water quality. His research, which is part of the UFS 2023 Impact Report, has drawn attention to localised incidences of terrestrial and aquatic contamination linked to sewage sludge management by local wastewater treatment plants.

Using mycofiltration to reclaim the quality of contaminated water

In Qwaqwa, wastewater treatment plants, however, are not the only source of river pollution, as a significant amount of river pollutants emanates directly from the communities that often dispose of their household waste directly into the waterways. This has led to unacceptable levels of pharmaceuticals such as biphenyl-4-ylacetic acid (an anti-inflammatory), efavirenz (an HIV medicine), and carbamazepine (an epilepsy medicine) ending up in rivers.

To attempt to reclaim the quality of contaminated water, ongoing research in Prof Voua Otomo’s laboratory involves the use of ‘mycofiltration’, i.e., the use of fungal mycelia for the purpose of water filtration. This relatively untapped eco-friendly technology is attracting more attention, yet its real merits are only now being established and documented scientifically.

“Various species of fungi have been explored in bioremediation studies, and those belonging to the Pleurotus genus (edible mushrooms) have demonstrated an exceptional ability in the biosorption of contaminants,” says Prof Voua Otomo.

In his field of research, Prof Voua Otomo says snails can be used as bioindicators (i.e., organisms used to assess the health of an environment or ecosystem, particularly by indicating the presence and impact of pollutants or other environmental stressors) or biomonitors (i.e., organisms or a biological systems used to assess the health of an environment, particularly by detecting changes in the levels of pollutants or other harmful substances).

“We designed a mycofilter made of mycelia from the mushroom species Pleurotus ostreatus and filtrated water contaminated with the organic insecticide imidacloprid and the inorganic chemical iron (III). The results showed that mycofiltration could remove up to 94% of iron (III) and 31% of imidacloprid.

“Mycofiltration works through a process called adsorption, which is the process where molecules, ions, or particles from a gas, liquid, or dissolved solid, stick to a surface. This happens when the adsorbate (the substance being adsorbed) attaches to the adsorbent (the surface it adheres to),” Prof Voua Otomo explains.

Mycofiltration viable and affordable for water remediation

This research is the brainchild of Sanele Mnkandla, a final-year PhD student in Prof Voua Otomo’s laboratory. “A few years ago, she suggested looking at mycofiltration as a means to improve the quality of contaminated water. Freshwater snails were the most suitable organisms to help assess the improvement of the water quality after mycofiltration,” explains Prof Voua Otomo.

According to him, they are currently exploring ways to upscale the mycofilter to improve the quality of larger bodies of water, including rivers. The duration of the process depends on the size of the filter, the amount of water to be filtered and the targeted chemicals. Bigger filters, explains Prof Voua Otomo, will filter larger amounts of water over a relatively longer time whereas smaller ones will be saturated quickly. The process could last from minutes to days.

“We have published a technical note on the topic and a proof of concept. We are currently testing this technology using wastewater effluent in the Qwaqwa region. We are also exploring local applications in rainwater harvesting.

“Mycofiltration is certainly a viable and affordable option for water remediation, which can find a wide range of applications in South Africa,” he says. 

Watch the video below

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept